Source:http://linkedlifedata.com/resource/pubmed/id/12208473
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2002-9-4
|
pubmed:abstractText |
Chlamydia pneumoniae may be involved in atherosclerosis by inducing inflammation as well as LDL oxidation. The transcription factor NF-kappa B is found in an active state in atherosclerotic lesions. This study examined the effect of C. pneumoniae exposure on the NF-kappa B system in human monocytic lineage cells. Short exposure to C. pneumoniae as well as chlamydial heat shock protein 60 activated NF-kappa B, accompanied by increased cytokine production. Incubation with C. pneumoniae-induced depletion of I kappa B-alpha and later I kappa B-epsilon which was preceded by I kappa B kinase complex activation. 4-Hydroxynonenal, an aldehyde LDL oxidation product, was shown to inhibit C. pneumoniae induced NF-kappa B activation by preventing I kappa B phosphorylation/proteolysis. During long-term incubation with C. pneumoniae I kappa B-alpha returned to baseline, whereas the levels of I kappa B-epsilon and p65 were upregulated. Interestingly, long-term preincubation with C. pneumoniae selectively prevented restimulation by this microorganism, which appears to be at least partly facilitated by inhibition of I kappa B proteolysis. C. pneumoniae-induced NF-kappa B activation as well as the inhibition of that effect under certain conditions may contribute to chronic inflammation with potential relevance to vascular disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/4-hydroxy-2-nonenal,
http://linkedlifedata.com/resource/pubmed/chemical/Aldehydes,
http://linkedlifedata.com/resource/pubmed/chemical/Culture Media,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/I-kappa B Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0021-9150
|
pubmed:author |
pubmed-author:BrandKorbinianK,
pubmed-author:DonathBernadetteB,
pubmed-author:FischerClaudiaC,
pubmed-author:JilgNikolausN,
pubmed-author:MiethkeThomasT,
pubmed-author:NeumeierDieterD,
pubmed-author:PageSharonS,
pubmed-author:PrebeckSigridS,
pubmed-author:WeberMarionM,
pubmed-author:da CostaClarissaC
|
pubmed:issnType |
Print
|
pubmed:volume |
165
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
79-88
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12208473-Aldehydes,
pubmed-meshheading:12208473-Blotting, Western,
pubmed-meshheading:12208473-Cells, Cultured,
pubmed-meshheading:12208473-Chlamydophila pneumoniae,
pubmed-meshheading:12208473-Culture Media,
pubmed-meshheading:12208473-Cytokines,
pubmed-meshheading:12208473-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:12208473-Enzyme Activation,
pubmed-meshheading:12208473-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:12208473-Humans,
pubmed-meshheading:12208473-I-kappa B Proteins,
pubmed-meshheading:12208473-Monocytes,
pubmed-meshheading:12208473-NF-kappa B,
pubmed-meshheading:12208473-Sensitivity and Specificity,
pubmed-meshheading:12208473-Signal Transduction
|
pubmed:year |
2002
|
pubmed:articleTitle |
Chlamydia pneumoniae activates IKK/I kappa B-mediated signaling, which is inhibited by 4-HNE and following primary exposure.
|
pubmed:affiliation |
Institute of Clinical Chemistry and Pathobiochemistry, Technische Universität München, Klinikum rechts der Isar, Ismaninger Strasse 22, 81675 München, Germany.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|